throbber
National Institute on Drug Abuse
`
`Principles of Drug Abuse
`Treatment for Criminal
`Justice Populations | A Research-Based Guide
`
`National Institutes of Health
`U.S. Department of Health
`and Human Services
`
`Page 1 of 40
`
`ALKERMES EXHIBIT 2006
`Amneal Pharmaceuticals LLC v. Alkermes Pharma Ireland Limited
`IPR2018-00943
`
`

`

`3
`
`Page 2 of 40
`
`Page 2 of 40
`
`

`

`PRINCIPLES OF
`DRUG ABUSE
`TREATMENT FOR
`CRIMINAL JUSTICE
`POPULATIONS
`1. Drug addiction is a brain disease that affects
`
`behavior. Drug addiction has well-recognized cognitive, behavioral,
`and physiological characteristics that contribute to continued use of
`drugs despite the harmful consequences. Scientists have also found
`that chronic drug abuse alters the brain’s anatomy and chemistry and
`that these changes can last for months or years after the individual
`has stopped using drugs. This transformation may help explain why
`addicted persons are at a high risk of relapse to drug abuse even
`after long periods of abstinence and why they persist in seeking drugs
`despite the consequences.
`
`2. Recovery from drug addiction requires
`
`effective treatment, followed by management of the
`problem over time. Drug addiction is a serious problem that
`can be treated and managed throughout its course. Effective drug
`abuse treatment engages participants in a therapeutic process, retains
`them in treatment for an appropriate length of time, and helps them
`learn to maintain abstinence. Multiple episodes of treatment may be
`required. Outcomes for drug abusing offenders in the community can
`be improved by monitoring drug use and by encouraging continued
`participation in treatment.
`
`3. Treatment must last long enough to produce
`
`stable behavioral changes. In treatment, the drug abuser
`is taught to break old patterns of thinking and behaving and to learn
`new skills for avoiding drug use and criminal behavior. Individuals with
`severe drug problems and co-occurring disorders typically need longer
`treatment (e.g., a minimum of 3 months) and more comprehensive
`services. Early in treatment, the drug abuser begins a therapeutic
`
`1
`
`Page 3 of 40
`
`

`

`PRINCIPLES
`
`process of change. In later stages, he or she addresses other
`problems related to drug abuse and learns how to manage them as
`well.
`
`4. Assessment is the (cid:191)rst step in treatment.
`
`A history of drug or alcohol use may suggest the need to conduct a
`comprehensive assessment to determine the nature and extent of
`an individual’s drug problems, establish whether problems exist in
`other areas that may affect recovery, and enable the formulation of
`an appropriate treatment plan. Personality disorders and other mental
`health problems are prevalent in offender populations; therefore,
`comprehensive assessments should include mental health evaluations
`with treatment planning for these problems.
`
`5. Tailoring services to (cid:191)t the needs of the
`
`individual is an important part of effective drug
`abuse treatment for criminal justice populations.
`Individuals differ in terms of age, gender, ethnicity and culture,
`problem severity, recovery stage, and level of supervision needed.
`Individuals also respond differently to different treatment approaches
`and treatment providers. In general, drug treatment should address
`issues of motivation, problemsolving, and skill-building for resisting
`drug use and criminal behavior. Lessons aimed at supplanting
`drug use and criminal activities with constructive activities and
`at understanding the consequences of one’s behavior are also
`important to include. Tailored treatment interventions can facilitate
`the development of healthy interpersonal relationships and improve
`the participant’s ability to interact with family, peers, and others in
`the community.
`
`6. Drug use during treatment should be carefully
`
`monitored. Individuals trying to recover from drug addiction may
`experience a relapse, or return to drug use. Triggers for drug relapse
`are varied; common ones include mental stress and associations with
`peers and social situations linked to drug use. An undetected relapse
`can progress to serious drug abuse, but detected use can present
`
`2
`
`Page 4 of 40
`
`

`

`opportunities for therapeutic intervention. Monitoring drug use through
`urinalysis or other objective methods, as part of treatment or criminal
`justice supervision, provides a basis for assessing and providing
`feedback on the participant’s treatment progress. It also provides
`opportunities to intervene to change unconstructive behavior—
`determining rewards and sanctions to facilitate change,
`and modifying treatment plans according to progress.
`
`7. Treatment should target factors that are
`
`associated with criminal behavior. “Criminal thinking” is
`a combination of attitudes and beliefs that support a criminal lifestyle
`and criminal behavior, such as feeling entitled to have things one’s
`own way, feeling that one’s criminal behavior is justi(cid:191)ed, failing to
`accept responsibility for one’s actions, and consistently failing to
`anticipate or appreciate the consequences of one’s behavior. This
`pattern of thinking often contributes to drug use and criminal behavior.
`Treatment that provides speci(cid:191)c cognitive skills training to help
`individuals recognize errors in judgment that lead to drug abuse and
`criminal behavior may improve outcomes.
`
`8. Criminal justice supervision should incorporate
`
`treatment planning for drug abusing offenders, and
`treatment providers should be aware of correctional
`supervision requirements. The coordination of drug abuse
`treatment with correctional planning can encourage participation in
`drug abuse treatment and can help treatment providers incorporate
`correctional requirements as treatment goals. Treatment providers
`should collaborate with criminal justice staff to evaluate each
`individual’s treatment plan and ensure that it meets correctional
`supervision requirements, as well as that person’s changing needs,
`which may include housing and child care; medical, psychiatric, and
`social support services; and vocational and employment assistance.
`For offenders with drug abuse problems, planning should incorporate
`the transition to community-based treatment and links to appropriate
`post-release services to improve the success of drug treatment
`and re-entry. Abstinence requirements may necessitate a rapid
`clinical response, such as more counseling, targeted intervention,
`
`3
`
`Page 5 of 40
`
`

`

`PRINCIPLES
`
`or increased medication, to prevent relapse. Ongoing coordination
`between treatment providers and courts or parole and probation
`of(cid:191)cers is important in addressing the complex needs of these
`re-entering individuals.
`
`9. Continuity of care is essential for drug abusers
`
`re-entering the community. Offenders who complete prison-
`based treatment and continue with treatment in the community have
`the best outcomes. Continuing drug abuse treatment helps the
`recently released offender deal with problems that become relevant
`after release, such as learning to handle situations that could lead
`to relapse, learning how to live drug-free in the community, and
`developing a drug-free peer support network. Treatment in prison or
`jail can begin a process of therapeutic change, resulting in reduced
`drug use and criminal behavior post-incarceration. Continuing drug
`treatment in the community is essential to sustaining these gains.
`
`10. A balance of rewards and sanctions
`
`encourages pro-social behavior and treatment
`participation. When providing correctional supervision of
`individuals participating in drug abuse treatment, it is important
`to reinforce positive behavior. Nonmonetary “social reinforcers,”
`such as recognition for progress or sincere effort, can be effective,
`as can graduated sanctions that are consistent, predictable, and
`clear responses to noncompliant behavior. Generally, less punitive
`responses are used for early and less serious noncompliance,
`with increasingly severe sanctions issuing from continued problem
`behavior. Rewards and sanctions are most likely to have the desired
`effect when they are perceived as fair and when they swiftly follow the
`targeted behavior.
`
`11. Offenders with co-occurring drug abuse and
`
`mental health problems often require an integrated
`treatment approach. High rates of mental health problems are
`found both in offender populations and in those with substance abuse
`problems. Drug abuse treatment can sometimes address depression,
`anxiety, and other mental health problems. Personality, cognitive,
`
`4
`
`Page 6 of 40
`
`

`

`and other serious mental disorders can be dif(cid:191)cult to treat and may
`disrupt drug treatment. The presence of co-occurring disorders may
`require an integrated approach that combines drug abuse treatment
`with psychiatric treatment, including the use of medication. Individuals
`with either a substance abuse or mental health problem should be
`assessed for the presence of the other.
`
`12. Medications are an important part of
`
`treatment for many drug abusing offenders.
`Medicines such as methadone, buprenorphine, and extended-release
`naltrexone have been shown to reduce heroin use and should be
`made available to individuals who could bene(cid:191)t from them. Effective
`use of medications can also be instrumental in enabling people
`with co-occurring mental health problems to function successfully
`in society. Behavioral strategies can increase adherence to
`medication regimens.
`
`13. Treatment planning for drug abusing
`
`offenders who are living in or re-entering the
`community should include strategies to prevent
`and treat serious, chronic medical conditions, such
`as HIV/AIDS, hepatitis B and C, and tuberculosis.
`The rates of infectious diseases, such as hepatitis, tuberculosis, and
`HIV/AIDS, are higher in drug abusers, incarcerated offenders, and
`offenders under community supervision than in the general population.
`Infectious diseases affect not just the offender, but also the criminal
`justice system and the wider community. Consistent with Federal
`and State laws, drug-involved offenders should be offered testing for
`infectious diseases and receive counseling on their health status and
`on ways to modify risk behaviors. Probation and parole of(cid:191)cers who
`monitor offenders with serious medical conditions should link them
`with appropriate health care services, encourage compliance with
`medical treatment, and re-establish their eligibility for public health
`services (e.g., Medicaid, county health departments) before release
`from prison or jail.
`
`5
`
`Page 7 of 40
`
`

`

`CONTENTS
`
`PRINCIPLES OF DRUG ABUSE TREATMENT
`FOR CRIMINAL JUSTICE POPULATIONS ....... 1
`PREFACE............................................................ 9
`ACKNOWLEDGMENTS ................................... 11
`INTRODUCTION ............................................... 12
`FREQUENTLY ASKED QUESTIONS (FAQS) .. 15
`1. Why do people involved in the criminal
`justice system continue abusing drugs? ....................................15
`2. Why should drug abuse treatment
`be provided to offenders? ...........................................................16
`3. How effective is drug abuse treatment
`for criminal justice-involved individuals? ....................................17
`4. Are all drug abusers in the criminal justice
`system good candidates for treatment? .....................................17
`5. Is legally mandated treatment effective?....................................18
`6. Are relapse risk factors different in
`offender populations? How should drug
`abuse treatment deal with these risk factors? ...........................19
`7. What treatment and other health services
`should be provided to drug abusers involved
`with the criminal justice system? ................................................20
`
`6
`
`Page 8 of 40
`
`

`

`8. How long should drug abuse treatment last for
`individuals involved in the criminal justice system? ...................20
`9. How can rewards and sanctions be used effectively
`with drug-involved offenders in treatment? ................................21
`10. What is the role of medications in
`treating substance abusing offenders? ......................................23
`11. How can the criminal justice and drug abuse
`treatment systems reduce the spread of HIV/AIDS,
`hepatitis, and other infectious diseases among
`drug abusing offenders? .............................................................25
`12. What works for offenders with co-occurring
`substance abuse and mental disorders? ...................................26
`13. Is providing drug abuse treatment to
`offenders worth the (cid:191)nancial investment? ..................................26
`14. What are the unique treatment needs of
`women in the criminal justice system? .......................................28
`15. What are the unique treatment needs of
`juveniles in the criminal justice system? ....................................29
`RESOURCES .................................................... 32
`REFERENCES .................................................. 34
`
`7
`
`Page 9 of 40
`
`

`

`8
`
`Page 10 of 40
`
`Page 10 of 40
`
`

`

`PREFACE
`
`From the time it was established
`in 1974, the National Institute
`on Drug Abuse (NIDA) has
`supported research on drug
`abuse treatment for people
`involved with the criminal justice
`system.
`
`Findings show unequivocally that providing comprehensive drug
`abuse treatment to criminal offenders works, reducing both drug
`abuse and criminal recidivism. The substantial prison population in
`the United States is attributable in large part to drug-related offenses
`and is accompanied by high rates of recidivism. As such,
`it is a matter of public health and safety to make drug abuse
`treatment a key component of the criminal justice system. Indeed,
`addressing the treatment needs of substance abusing offenders
`is critical to reducing overall crime and other drug-related societal
`burdens, such as lost job productivity and family disintegration.
`Scienti(cid:191)c research shows that drug abuse treatment can work
`even when an individual enters it under legal mandate. However,
`only a small percentage of those who need treatment actually
`receive it, and often the treatment provided is inadequate. To be
`effective, treatment must begin in prison and be sustained after
`
`9
`
`Page 11 of 40
`
`

`

`PREFACE
`
`release through participation in community treatment programs. By
`engaging in a continuing therapeutic process, individuals can learn
`how to avoid relapse and withdraw from a life of crime.
`As re(cid:192)ected in our collaborative Criminal Justice(cid:177)Drug Abuse
`Treatment Studies (CJ(cid:177)DATS) Initiative, NIDA is committed to
`working across organizational boundaries to improve substance
`abuse treatment services. Multiple studies from different scienti(cid:191)c
`disciplines have helped us understand the basic neurobiology of
`addiction, along with what constitutes effective treatment. Now
`we are at the point where the implementation of evidence-based
`treatment principles is called for within the criminal justice system to
`improve public health and public safety by reducing both drug use
`and crime.
`This booklet—a complement to NIDA’s Principles of Drug Addiction
`Treatment: A Research-Based Guide—is intended to describe the
`treatment principles and research (cid:191)ndings that have particular
`relevance to the criminal justice community and to treatment
`professionals working with drug abusing offenders. It is divided into
`three main sections: (1) research (cid:191)ndings on addicted offenders
`distilled into 13 essential principles (see pages 1(cid:177)5), (2) a series of
`frequently asked questions (FAQs) about drug abuse treatment for
`those involved with the criminal justice system, and (3) a resource
`section that provides Web sites for additional information. This
`booklet and other resources on drug abuse and the criminal justice
`system are available on NIDA’s Web site at http://www.drugabuse.
`gov/drugpages/cj.html.
`With the release of this landmark publication’s revised edition, we
`are optimistic that correctional agencies have begun to understand
`how drug treatment programs are helping achieve public health and
`safety goals for the Nation.
`
`Nora D. Volkow, M.D.
`Director
`National Institute on Drug Abuse
`
`10
`
`Page 12 of 40
`
`

`

`ACKNOWLEDGMENTS
`
`This publication was written by Bennett W. Fletcher, Ph.D.,
`Redonna (cid:46). Chandler, Ph.D., and the Of(cid:191)ce of Science Policy and
`Communications, National Institute on Drug Abuse.
`This publication is in the public domain and may be used or
`reproduced in its entirety without permission from NIDA or the authors.
`Citation of the source is appreciated.
`The U.S. Government does not endorse or favor any speci(cid:191)c
`commercial product or company. Trade, proprietary, or company
`names appearing in this publication are used only because they are
`considered essential in the context of the studies described here.
`
`11
`
`Page 13 of 40
`
`

`

`INTRODUCTION
`
`The connection between
`drug abuse and crime is well
`known.
`
`Drug abuse is implicated in at least three types of drug-
`related offenses: (1) offenses de(cid:191)ned by drug possession or
`sales, (2) offenses directly related to drug abuse (e.g., stealing
`to get money for drugs), and (3) offenses related to a lifestyle
`that predisposes the drug abuser to engage in illegal activity, for
`example, through association with other offenders or with illicit
`markets. Individuals who use illicit drugs are more likely to commit
`crimes, and it is common for many offenses, including violent crimes,
`to be committed by individuals who had used drugs or alcohol prior
`to committing the crime, or who were using at the time of the offense.
`According to 2012 statistics from the Department of Justice’s
`(DOJ’s) Bureau of Justice Statistics (BJS), the total correctional
`population is 6,937,600, with 4,794,000 individuals on probation or
`under parole supervision, and drug law violations accounting for the
`most common type of criminal offense (Glaze and Herberman 2013).
`In a survey of State and Federal prisoners, BJS estimated that about
`half of the prisoners met Diagnostic and Statistical Manual for Mental
`Disorders (DSM) criteria for drug abuse or dependence, and yet
`fewer than 20 percent who needed treatment received it (Chandler
`et al. 2009; Mumola and Karberg 2006). Of those surveyed, 14.8
`percent of State and 17.4 percent of Federal prisoners reported
`having received drug treatment since admission (Mumola and
`Karberg 2006).
`
`12
`
`Page 14 of 40
`
`

`

`Treatment offers
`the best alternative
`for interrupting the
`drug abuse/criminal
`justice cycle.
`
`Juvenile justice systems also report high levels of drug abuse.
`In 2008, approximately 10 percent of the estimated 2.1 million
`juvenile arrests were for drug abuse or underage drinking violations
`(Puzzanchera 2009). As many as two-thirds of detained juveniles
`may have a substance use disorder (SUD); female juveniles who
`enter the system generally have higher SUD rates than males
`(McClelland et al. 2004a).
`Although the past several decades
`have witnessed an increased interest
`in providing substance abuse
`treatment services for criminal
`justice offenders, only a small
`percentage of offenders has access
`to adequate services, especially in jails
`and community correctional facilities
`(Taxman et al. 2007; Sabol et al. 2010). Not
`only is there a gap in the availability of these services for offenders,
`but often there are few choices in the types of services provided.
`Treatment that is of insuf(cid:191)cient quality and intensity or that is not
`well suited to the needs of offenders may not yield meaningful
`reductions in drug use and recidivism. Untreated substance abusing
`offenders are more likely than treated offenders to relapse to drug
`abuse and return to criminal behavior. This can lead to re-arrest
`and re-incarceration, jeopardizing public health and public safety
`and taxing criminal justice system resources. Treatment is the most
`effective course for interrupting the drug abuse/criminal justice cycle
`for offenders with drug abuse problems.
`Drug abuse treatment can be incorporated into criminal justice
`settings in a variety of ways. Examples include treatment in prison
`followed by community-based treatment after release; drug courts
`that blend judicial monitoring and sanctions with treatment by
`imposing treatment as a condition of probation; and treatment under
`parole or probation supervision. Drug abuse treatment can bene(cid:191)t
`from the cross-agency coordination and collaboration of criminal
`justice professionals, substance abuse treatment providers, and
`other social service agencies. By working together, the criminal
`justice and treatment systems can optimize resources to bene(cid:191)t the
`health, safety, and well-being of the individuals and communities
`they serve.
`
`13
`
`Page 15 of 40
`
`

`

`14
`
`Page 16 of 40
`
`Page 16 of 40
`
`

`

`FREQUENTLY ASKED
`QUESTIONS (FAQS)
`
`1. Why do people involved in the criminal
`
`Normal
`
`Cocaine Abuser
`(100 days of
`abstinence)
`
`justice system continue abusing drugs?
`The answer to this perplexing question spans basic neurobiological,
`psychological, social, and environmental factors. The repeated use of
`addictive drugs eventually changes how the brain functions. Resulting
`brain changes, which accompany the transition from voluntary to
`compulsive drug use, affect the brain’s natural inhibition and reward
`centers, causing the
`Addictive drugs cause
`addicted person to
`long-lasting changes in the brain
`use drugs in spite of
`the adverse health,
`social, and legal
`consequences (Baler
`and Volkow 2006;
`Volkow et al. 2010;
`and Chandler et
`al. 2009). Craving
`for drugs may be
`triggered by contact
`with the people,
`places, and things
`associated with prior
`drug use, as well as
`by stress. Forced
`abstinence (when it occurs) is not treatment, and it does not cure
`addiction. Abstinent individuals must still learn how to avoid relapse,
`including those who may have been abstinent for a long period of time
`while incarcerated.
`
`Cocaine Abuser
`(10 days of
`abstinence)
`
`PET scans showing glucose metabolism in healthy
`(normal) and cocaine-addicted brains. Even after 100
`days of abstinence, glucose metabolism has not returned
`to normal levels.
`
`Source: Volkow et al., 1992, 1993.
`
`15
`
`Page 17 of 40
`
`

`

`FREQUENTLY ASKED QUESTIONS
`
`Potential risk factors for released offenders include pressures
`from peers and family members to return to drug use and a criminal
`lifestyle. Tensions of daily life—violent associates, few opportunities
`for legitimate employment, lack of safe housing, and even the need
`to comply with correctional supervision conditions—can also create
`stressful situations that can precipitate a relapse to drug use.
`Research on how the brain is affected by drug abuse promises
`to teach us much more about the mechanics of drug-induced brain
`changes and their relationship to addiction. Research also reveals
`that with effective drug abuse treatment, individuals can overcome
`persistent drug effects and lead healthy, productive lives.
`
`2. Why should drug abuse treatment
`
`be provided to offenders?
`The case for treating drug abusing offenders is compelling. Drug
`abuse treatment improves outcomes for drug abusing offenders and
`has bene(cid:191)cial effects for public health and safety. Effective treatment
`decreases future drug use and drug-related criminal behavior, can
`improve the individual’s relationships with his or her family, and may
`improve prospects for employment. In addition, it can save lives: A
`retrospective study of more than 30,000 Washington State inmates
`found that during the (cid:191)rst 2 weeks after release, the risk of death
`among former inmates was more than 12 times that among other
`residents, with drug overdose being the leading cause (Binswanger et
`al. 2007).
`Outcomes for substance abusing individuals can be improved when
`criminal justice personnel work in tandem with treatment providers
`on drug abuse treatment needs and supervision requirements.
`Treatment needs that can be assessed after arrest include substance
`abuse severity, mental health problems, and physical health. Defense
`attorneys, prosecutors, and judges need to work together during the
`prosecution and sentencing phases of the criminal justice process
`to determine suitable treatment programs that meet the offender’s
`needs. Through drug courts, diversion programs, pretrial release
`programs that are conditional on treatment, and conditional probation
`with sanctions, the offender can participate in community-based drug
`
`16
`
`Page 18 of 40
`
`

`

`abuse treatment while under criminal justice supervision. In some
`instances, the judge may recommend that the offender participate
`in treatment while serving jail or prison time or require it as part of
`continuing correctional supervision post-release.
`
`3. How effective is drug abuse treatment
`
`for criminal justice-involved individuals?
`Treatment is an effective intervention for drug abusers, including
`those who are involved with the criminal justice system. However, the
`effectiveness of drug treatment depends on both the individual and the
`program, and on whether interventions
`and treatment services are available
`and appropriate for the individual’s
`needs. To alter attitudes, beliefs,
`and behaviors that support
`drug use, the drug abuser must
`engage in a therapeutic change
`process, which may include
`medications to help prevent relapse.
`Longitudinal outcome studies (cid:191)nd
`that those who participate in community-based drug abuse treatment
`programs commit fewer crimes than those who do not participate
`(Prendergast et al. 2002; Butzin et al. 2006; and Kinlock et al. 2009).
`
`Outcomes can be
`improved when criminal
`justice personnel work
`in tandem with treatment
`providers.
`
`4. Are all drug abusers in the criminal justice
`
`system good candidates for treatment?
`A history of drug use does not in itself indicate the need for drug
`abuse treatment. Offenders who meet drug dependence criteria
`should be given higher priority for treatment than those who do
`not. Less intensive interventions, such as drug abuse education
`or self-help group participation, may be appropriate for those not
`meeting criteria for drug dependence. Services such as family-
`based interventions for juveniles, psychiatric treatment, or cognitive-
`behavioral interventions for changing “criminal thinking” may be a
`higher priority for some offenders, and individuals with mental health
`problems may require specialized services (see FAQ Nos. 6 and 12).
`
`17
`
`Page 19 of 40
`
`

`

`FREQUENTLY ASKED QUESTIONS
`
`Low motivation to participate in treatment or to end drug abuse
`should not preclude access to treatment if other criteria are met.
`Motivational enhancement interventions may be useful in these
`cases. Examples include motivational interviewing and contingency
`management techniques, which often provide tangible rewards in
`exchange for meeting program goals. Legal pressure that encourages
`abstinence and treatment participation may also help these individuals
`by improving retention and prompting longer treatment stays.
`Drug abuse treatment is also effective for offenders who have
`a history of serious and violent crime, particularly if they receive
`intensive, targeted services. The economic bene(cid:191)ts in avoided crime
`costs and those of crime victims (e.g., medical costs, lost earnings,
`and loss in quality of life) may be substantial for these high-risk
`offenders. Treating them requires a high degree of coordination
`between drug abuse treatment providers and criminal justice
`personnel to ensure that the prisoners receive needed treatment and
`other services that will help prevent criminal recidivism.
`
`5. Is legally mandated treatment effective?
`
`Often, the criminal justice system can apply legal pressure to
`encourage offenders to participate in drug abuse treatment; or
`treatment can be mandated through a drug court or as a condition
`of pretrial release, probation, or parole. A large percentage of those
`admitted to drug abuse treatment cite legal pressure as an important
`reason for seeking treatment. Most studies suggest that outcomes
`for those who are legally pressured to enter
`treatment are as good as or better than
`outcomes for those who entered treatment
`without legal pressure. Individuals under
`legal pressure also tend to have higher
`attendance rates and remain in treatment
`for longer periods, which can also have a
`positive impact on treatment outcomes.
`
`Legal pressure can
`increase treatment
`attendance and
`improve retention.
`
`18
`
`Page 20 of 40
`
`

`

`Returning to environments
`associated with drug use
`may trigger cravings and
`cause a relapse.
`
`6. Are relapse risk factors different in
`
`offender populations? How should drug abuse
`treatment deal with these risk factors?
`Often, drug abusing offenders have problems in other areas.
`Examples include family dif(cid:191)culties, limited social skills, educational
`and employment problems, mental health disorders, infectious
`diseases, and other medical issues. Treatment should take these
`problems into account, because they can increase the risk of drug
`relapse and criminal recidivism if left unaddressed.
`Stress is often a contributing factor
`to relapse, and offenders who are
`re-entering society face many
`challenges and stressors,
`including reuniting with family
`members, securing housing, and
`complying with criminal justice
`supervision requirements. Even
`the many daily decisions that most
`people face can be stressful for those
`recently released from a highly controlled prison environment.
`Other threats to recovery include a loss of support from family or
`friends, which incarcerated people may experience. Drug abusers
`returning to the community may also encounter people from their
`lives who are still involved in drugs or crime and be enticed to resume
`a criminal and drug using lifestyle. Returning to environments or
`activities associated with prior drug use may trigger strong cravings
`and cause a relapse. A coordinated approach by treatment and
`criminal justice staff provides the best way to detect and intervene with
`these and other threats to recovery. In any case, treatment is needed
`to provide the skills necessary to avoid or cope with situations that
`could lead to relapse.
`Treatment staff should identify the offender’s unique relapse risk
`factors and periodically re-assess and modify the treatment plan
`as needed. Generally, continuing or re-emerging drug use during
`treatment requires a clinical response—either increasing the amount
`or level of treatment, or changing the treatment intervention.
`
`19
`
`Page 21 of 40
`
`

`

`FREQUENTLY ASKED QUESTIONS
`
`7. What treatment and other health services
`
`should be provided to drug abusers involved
`with the criminal justice system?
`One of the goals of treatment planning is to match evidence-based
`interventions to individual needs at each stage of drug treatment. Over
`time, various combinations of treatment services may be required.
`Evidence-based interventions include cognitive-behavioral therapy to
`help participants learn positive social and coping skills, contingency
`management approaches to reinforce positive behavioral change, and
`motivational enhancement to increase treatment engagement and
`retention. In those addicted to opioid drugs, agonist/partial agonist
`medications can also help normalize brain function, and antagonist
`medications can facilitate abstinence. For juvenile offenders,
`treatments that involve the family and other aspects of the drug
`abuser’s environment have established ef(cid:191)cacy.
`Drug abuse treatment plans for incarcerated offenders can facilitate
`successful re-entry into the community by incorporating relevant
`transition plans and services. Drug abusers often have mental and
`physical health, family counseling, parenting, educational, and
`vocational needs, so medical, psychological, and social services are
`often crucial components of successful treatment. Case management
`approaches can be used to provide assistance in obtaining and
`integrating drug abuse treatment with community services.
`
`8. How long should drug abuse treatment last for
`
`individuals involved in the criminal justice system?
`While individuals progress through drug abuse treatment at
`different rates, one of the most reliable (cid:191)ndings in treatment
`research is that lasting reductions in criminal activity and drug
`abuse are related to length of t

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket